Expanded safety analysis of pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukemia and myelodysplastic syndromes
暂无分享,去创建一个
M. Maris | D. DeAngelo | F. Giles | J. Altman | H. Erba | B. Dezube | R. Swords | Z. Hua | J. Watts | B. Medeiros | H. Faessel | F. Anwer | F. Sedarati | H. Stein | Zhaowei Hua | Michael B. Maris